SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-286057
Filing Date
2019-11-06
Accepted
2019-11-06 17:16:56
Documents
9
Period of Report
2019-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828966d8k.htm 8-K 27205
2 EX-1.1 d828966dex11.htm EX-1.1 190028
3 EX-5.1 d828966dex51.htm EX-5.1 9157
4 EX-99.1 d828966dex991.htm EX-99.1 10241
5 EX-99.2 d828966dex992.htm EX-99.2 13864
6 GRAPHIC g828966blakes1.jpg GRAPHIC 4955
7 GRAPHIC g828966blakes2.jpg GRAPHIC 6542
8 GRAPHIC g828966blakes3.jpg GRAPHIC 2763
9 GRAPHIC g828966g67v98.jpg GRAPHIC 2984
  Complete submission text file 0001193125-19-286057.txt   276051
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 191197248
SIC: 2834 Pharmaceutical Preparations